These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20472161)

  • 1. Disease activity and venous thromboembolism in inflammatory bowel disease.
    Ghosh T; Ford AC; Everett S
    Lancet; 2010 May; 375(9727):1690; author reply 1690-1. PubMed ID: 20472161
    [No Abstract]   [Full Text] [Related]  

  • 2. Disease activity and venous thromboembolism in inflammatory bowel disease.
    Thachil J
    Lancet; 2010 May; 375(9727):1689; author reply 1690-1. PubMed ID: 20472160
    [No Abstract]   [Full Text] [Related]  

  • 3. Disease activity and venous thromboembolism in inflammatory bowel disease.
    Valsecchi ME; Damilano CP
    Lancet; 2010 May; 375(9727):1690; author reply 1690-1. PubMed ID: 20472163
    [No Abstract]   [Full Text] [Related]  

  • 4. Disease activity and venous thromboembolism in inflammatory bowel disease.
    Koutroubakis IE; Pena AS
    Lancet; 2010 May; 375(9727):1689; author reply 1690-1. PubMed ID: 20472159
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylaxis of venous thromboembolism in IBD.
    Nguyen GC; Yeo EL
    Lancet; 2010 Feb; 375(9715):616-7. PubMed ID: 20149426
    [No Abstract]   [Full Text] [Related]  

  • 6. Venous thromboembolism in inflammatory bowel disease: an epidemiological review.
    Murthy SK; Nguyen GC
    Am J Gastroenterol; 2011 Apr; 106(4):713-8. PubMed ID: 21407182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammatory bowel disease and venous thromboembolisms].
    Delhougne N; Colard A; Louis E
    Rev Med Liege; 2018 Sep; 73(9):462-467. PubMed ID: 30188032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease.
    Yuhara H; Steinmaus C; Corley D; Koike J; Igarashi M; Suzuki T; Mine T
    Aliment Pharmacol Ther; 2013 May; 37(10):953-62. PubMed ID: 23550660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.
    Grainge MJ; West J; Card TR
    Lancet; 2010 Feb; 375(9715):657-63. PubMed ID: 20149425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism with inflammatory bowel disease.
    Freeman HJ
    World J Gastroenterol; 2008 Feb; 14(7):991-3. PubMed ID: 18286676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Questionnaire for assessing the risk of venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian antithrombotic guideline entitled "Risk reduction and treatment of venous thromboembolism"].
    Dávid M; Losonczy H; Udvardy M; Boda Z; Blaskó G; Tar A; Pfliegler G
    Orv Hetil; 2010 Aug; 151(34):1365-74. PubMed ID: 20705551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IBD: which patients with IBD are at risk of venous thromboembolism?
    Koutroubakis IE
    Nat Rev Gastroenterol Hepatol; 2010 Jun; 7(6):307-8. PubMed ID: 20523349
    [No Abstract]   [Full Text] [Related]  

  • 13. [Increased risk of venous thromboembolism and arterial cardiovascular events in patients with inflammatory bowel disease].
    Lund Kristensen S; Ahlehoff O; Lindhardsen J; Gislason G; Nielsen OH; Hansen PR
    Ugeskr Laeger; 2012 Nov; 174(48):3003-6. PubMed ID: 23195352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of venous thromboembolism in patients with inflammatory bowel disease.
    Koutroumpakis EI; Tsiolakidou G; Koutroubakis IE
    Semin Thromb Hemost; 2013 Jul; 39(5):461-8. PubMed ID: 23629820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous and arterial disease in inflammatory bowel disease.
    Tan VP; Chung A; Yan BP; Gibson PR
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1095-113. PubMed ID: 23662785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Risk of Blood Transfusion With the Use of Pharmacologic Venous Thromboembolism Prophylaxis During Hospitalization for Inflammatory Bowel Disease Exacerbation: A Time to Event Analysis.
    Khuwaja S; Kohn N; Sanghani SS; Khan S; Swaminath A; Sultan K
    Am J Ther; 2023 May; 30(3):e288-e291. PubMed ID: 37278710
    [No Abstract]   [Full Text] [Related]  

  • 17. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.
    Nguyen GC; Bernstein CN; Bitton A; Chan AK; Griffiths AM; Leontiadis GI; Geerts W; Bressler B; Butzner JD; Carrier M; Chande N; Marshall JK; Williams C; Kearon C
    Gastroenterology; 2014 Mar; 146(3):835-848.e6. PubMed ID: 24462530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism risk in patients with inflammatory bowel disease: defining the benefits of pharmacologic prophylaxis.
    Sultan K; Brun A; Spyropoulos AC
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1577. PubMed ID: 24703865
    [No Abstract]   [Full Text] [Related]  

  • 19. Mind the gap: venous thromboembolism prophylaxis in patients hospitalized with inflammatory bowel disease.
    Allen JI
    Dig Dis Sci; 2013 Jan; 58(1):1-4. PubMed ID: 23179161
    [No Abstract]   [Full Text] [Related]  

  • 20. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.